Physician profile
Shawn Maynard
NPI 1487815403
$3,478.16
in general payments reported to CMS, 2019-2025
19 companies · $489 in 2025
The $489 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $987 · 2020: $174 · 2021: $149 · 2022: $476 · 2023: $504 · 2024: $699 · 2025: $489.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,692.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,691.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,015.68 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $579.62 | 2019-2024 | |
| Abbvie INC. | $514.76 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $293.27 | 2019-2024 | Xarelto |
| Pfizer INC. | $271.52 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $153.58 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $140.94 | 2019-2023 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $118.30 | 2019 | |
| Boston Scientific Corporation | $71.61 | 2022-2025 | Watchman Access System |
| Amgen INC. | $55.23 | 2019 | |
| Abbott Laboratories | $50.94 | 2024 | Cardiomems |
| Allergan, INC. | $44.00 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $36.48 | 2019-2021 | |
| Kestra Medical Technology Services, INC. | $35.26 | 2024 | Assure Wcd |
| Smith+Nephew, INC. | $30.75 | 2023-2025 | Collagenase Santyl |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $18.58 | 2019 | |
| Gilead Sciences, INC. | $16.24 | 2025 | Veklury |
| Janssen Scientific Affairs, LLC | $16.19 | 2023 | Xarelto |
| Advanced Respiratory, INC | $15.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shawn Maynard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.